Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing
He holds a brown belt under Josh Vogel
The FDA lists BPC-157 among bulk drug substances used in compounding that present significant safety risks, which limits routine compounding and prescription access in the United States
Therapeutic Potential BPC-157 is modified for greater stability than its parent compound and is shown to have systemic effects without the need for a carrier agent
Pure Glow Fusion is a targeted peptide blend designed to support skin quality and tissue recovery from the inside out
TB-500's parent Thymosin -4 has been administered at micrograms-per-kilogram parenteral dosing in cardiac and corneal model systems